OptiBiotix Health has entered into a joint development agreement with a multinational.
The Agreement allows for the development of food and Over The Counter products containing OptiBiotix’s SlimBiome technology for the Asian market.
The multinational is a major supplier of nutritional solutions to the food, beverage, nutraceutical and pharmaceutical industries within Asia, and increasingly across global markets.
The aim of the Agreement is to develop weight management products containing SlimBiome technology in a range of foods and OTC products which, if successful, will be launched into the Asian market in the second half of 2017.
The Company requires its identity and commercial details to remain confidential and no further details can be disclosed at this time.
Discussions are ongoing and it is hoped a further announcement can be made in due course.
Story provided by StockMarketWire.com